<DOC>
	<DOCNO>NCT02624765</DOCNO>
	<brief_summary>Few study specifically design address health concern relevant pregnancy . The consequence lack evidence best clinical practice . This include mother baby pregnancy complicate abnormally fast heart rate 300 beat per minute due supraventricular tachyarrhythmia ( SVA ) unborn baby ( fetus ) . Although fetal SVA , include atrial flutter ( AF ) form supraventricular tachycardia ( SVT ) , common cause intend in-utero fetal therapy , none medication use date evaluate effect mother baby randomize control trial ( RCT ) . As consequence , physician need make decision management pregnancy without evidence control trial drug efficacy safety consensus among specialist optimal management . The Fetal Atrial Flutter Supraventricular Tachycardia ( FAST ) Therapy Trial prospective multi-center trial address knowledge gap guide future fetal SVA therapy best care . Study component FAST include three prospective sub-studies determine efficacy safety commonly use transplacental drug regimen suppress fetal AF without hydrops ( RCT A ) , SVT without hydrops ( RCT B ) , SVT hydrops ( RCT C ) . All RCTs open label phase III trial standard 1st line therapy , either start monotherapy ( hydrops ) dual therapy ( hydrops ) . The primary study aim probability normal pregnancy outcome treatment start Digoxin Sotalol ( AF without hydrops ) ; Digoxin Flecainide ( SVT without hydrops ) ; Digoxin plus Sotalol Digoxin plus Flecainide ( SVT hydrops ) . The study also include possibility enroll non-randomized subject prospective Registry document outcome alternative management .</brief_summary>
	<brief_title>FAST Therapy Trial Fetal Tachyarrhythmia</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Atrial Flutter</mesh_term>
	<mesh_term>Tachycardia , Supraventricular</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Digoxin</mesh_term>
	<mesh_term>Sotalol</mesh_term>
	<mesh_term>Flecainide</mesh_term>
	<criteria>Maternal capacity competence make health care decision Maternal capacity competence understand follow medical instruction Mother provide write informed consent participate Fetal AF without hydrops SVT without hydrops SVT hydrops Tachyarrhythmia significant enough justify immediate transplacental pharmacological treatment : Tachycardia ≥ 170 bpm +100 % time ( ≤ 30 0/7 week gestation ) Tachycardia ≥ 180 bpm least 10 % observation time 30 minute longer Tachycardia ≥ 280 bpm ( irrespective SVA duration ) SVT fetal hydrops ( irrespective duration ) Gestational age &lt; 37 0/7 week time enrolment Untreated time enrolment Singleton Pregnancy Healthy mother ± normal pretreatment cardiovascular finding : ECG without significant abnormality ( sinus rhythm ; QTc ≤ 0.47 ; PR ≤ 0.2 sec ; QRS : ≤ 0.12 sec ; isolate PACs PVCs isolate complete right bundle branch block allow ) Resting heart rate ≥ 50 bpm Systolic BP ≥ 85 bpm Any maternalfetal condition associate high odds premature delivery and/or death ( e.g . severe IUGR ; premature rupture membrane ; lifethreatening maternal disease ( incl . preeclampsia ; HELLP syndrome ) ; severe congenital fetal abnormality ( T 13 18 ; surgery death expect &lt; 1 month ) ) Any relevant preexisting maternal heart condition ( open heart surgery ; sick sinus syndrome ; long QT , Brugada syndrome ; ventricular tachycardia ; WPW syndrome ; high degree heart block ; cardiomyopathy ) Relevant preexist maternal obstructive airway disease include asthma Maternal history chronic substance abuse Maternal intake QTprolonging medication ( link complete list mediation REDCap : http : //www.crediblemeds.org/pdftemp/pdf/CompositeList.pdf ) Maternal serum potassium level &lt; 3.3 mEq/L ( start treatment ) Maternal ionized serum calcium level &lt; 1 mmol/l ( start treatment ) Maternal serum creatinine level &gt; 1.1 mg/dl</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>RCT A : Fetal Atrial Flutter without Hydrops</keyword>
	<keyword>RCT B : Fetal Supraventricular Tachycardia without Hydrops</keyword>
	<keyword>RCT C : Fetal Supraventricular Tachycardia Hydrops</keyword>
</DOC>